HERON THERAPEUTICS, INC. /DE/ (HRTX) › RevenueHERON THERAPEUTICS, INC. /DE/ (HRTX) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $1.28M2017: $30.77M2018: $77.47M2019: $145.97M2020: $88.64M2021: $86.35M2022: $107.67M2023: $127.04M2024: $144.28M2025: $154.90M$154.90M2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$154.90M+7.4%2024$144.28M+13.6%2023$127.04M+18.0%2022$107.67M+24.7%2021$86.35M-2.6%2020$88.64M-39.3%2019$145.97M+88.4%2018$77.47M+151.8%2017$30.77M+2305.6%2016$1.28M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share